Data Foundry

Drug recalls 2015

KETOROLAC Tromethamine Inj — Class II drug recall D-1241-2015

Ongoing recall by Hospira Inc., reported 2015-07-22, distributed nationwide. Crystallization; identified as calcium salt of Ketorolac

Recall numberD-1241-2015
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmHospira Inc., Lake Forest, IL, United States
Recall initiated2015-06-30
Classified2015-07-15
Reported by FDA2015-07-22
DistributedNationwide (US)
Countries outside the USCA, SG
NDC00409-3793, 00409-3793-01, 00409-3793-19, 00409-3793-25, 00409-3795, 00409-3795-01, 00409-3795-19, 00409-3795-25, 00409-3795-49, 00409-3796, 00409-3796-01, 00409-3796-19, 00409-3796-25
Lot numbers32106DK, 32220DK, 32221DK, 33235DK, 33236DK, 34163DK, 34164DK, 39263DK, 39264DK
Expiration dates2015-07-01, 2015-08-01, 2015-09-01, 2015-10-01, 2015-11-01, 2016-02-01, 2016-03-01, 2016-06-01, 2016-07-01, 2016-09-01, 2016-10-01

Product

KETOROLAC Tromethamine Inj., USP, 30 mg (30 mg/mL), 1 mL Fill, Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-3795-01 --- Also labeled under NOVAPLUS label NDC 0409-3795-49

Reason for recall

Crystallization; identified as calcium salt of Ketorolac

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1241-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.